These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16374312)

  • 1. Hurdles and opportunities for a venture capitalist investing in therapies for orphan retinal diseases.
    Blair JC
    Retina; 2005 Dec; 25(8 Suppl):S105-S108. PubMed ID: 16374312
    [No Abstract]   [Full Text] [Related]  

  • 2. Convincing a venture capitalist to invest in your idea.
    Dooley JF; Dooley JF
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980
    [No Abstract]   [Full Text] [Related]  

  • 3. Filters for preparing to meet a venture capitalist.
    Christoffersen R
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE49-50. PubMed ID: 12874981
    [No Abstract]   [Full Text] [Related]  

  • 4. The rise of European venture capital for biotechnology.
    Howell M; Trull M; Dibner MD
    Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of angels in starting a US biotech venture.
    Sohl J
    Nat Biotechnol; 2005 Feb; 23(2):263-4. PubMed ID: 15724275
    [No Abstract]   [Full Text] [Related]  

  • 6. Other ways of financing your company.
    Aldag J; Kessel M; Ibrahim A; Hill R; McCubbin P
    Nat Biotechnol; 2008 Feb; 26(2):155-7. PubMed ID: 18273945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venture capital for the pharmacologist.
    Miller LG
    Mol Interv; 2001 Dec; 1(5):242-4. PubMed ID: 14993362
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges in genetic testing for clinical trials of inherited and orphan retinal diseases.
    Stone EM
    Retina; 2005 Dec; 25(8 Suppl):S72-S73. PubMed ID: 16374347
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of biotechnology funding: An interview with venture capitalist Dennis Purcell. Interviewed by Elaine Musgrave.
    Purcell D
    Clin Transl Sci; 2009 Oct; 2(5):320-1. PubMed ID: 20443914
    [No Abstract]   [Full Text] [Related]  

  • 10. Looking at US versus European exit opportunities.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges associated with clinical trials for inherited and orphan retinal diseases.
    Fishman GA
    Retina; 2005 Dec; 25(8 Suppl):S10-S12. PubMed ID: 16374308
    [No Abstract]   [Full Text] [Related]  

  • 12. Big pharma wants you.
    Mack GS
    Nat Biotechnol; 2006 Nov; 24(11):1317-9. PubMed ID: 17162751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoreceptor cell rescue in inherited and orphan retinal diseases: disease-specific requirements.
    Dryja TP
    Retina; 2005 Dec; 25(8 Suppl):S13-S14. PubMed ID: 16374317
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond basic research for inherited and orphan retinal diseases: successes and challenges.
    Chader GJ
    Retina; 2005 Dec; 25(8 Suppl):S15-S17. PubMed ID: 16374318
    [No Abstract]   [Full Text] [Related]  

  • 15. Design of phase III clinical trials for treatments of orphan retinal diseases: an overview of considerations.
    Hyman L
    Retina; 2005 Dec; 25(8 Suppl):S69-S71. PubMed ID: 16374346
    [No Abstract]   [Full Text] [Related]  

  • 16. Boutiques reborn in 2003.
    Surendran A
    Nat Biotechnol; 2004 Mar; 22(3):353-4. PubMed ID: 15017987
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings of the First International Symposium on Translational Clinical Research for Inherited and Orphan Retinal Diseases. November 5-7, 2004. Washington, DC, USA.
    Retina; 2005 Dec; 25(8 Suppl):S1-113. PubMed ID: 16509005
    [No Abstract]   [Full Text] [Related]  

  • 18. A network of patients with orphan retinal diseases for clinical trials: goals, structure, challenges.
    Weleber RG
    Retina; 2005 Dec; 25(8 Suppl):S66-S67. PubMed ID: 16374344
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotech IPOs--flop or pop?
    Jacobs T
    Nat Biotechnol; 2004 Aug; 22(8):949. PubMed ID: 15286641
    [No Abstract]   [Full Text] [Related]  

  • 20. The national eye institute: translational clinical research initiatives on inherited and orphan retinal diseases: personal observations.
    Sieving PA
    Retina; 2005 Dec; 25(8 Suppl):S8-S9. PubMed ID: 16374351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.